In this report, we aimed to explore the role of Arl4c in pancreatic cancer growth and drug resistance, as well as PSC activation, further determine its effect on tumor-stromal interactions, and reveal the underlying mechanism. This evidence concerns the gene ARL4C and pancreatic neoplasm.